Good Scientists, Bad Science? Clinging To A 'Dubious' Position Can Destroy A Career

Case Two: Harold Hilman’s attack on electron microscopy may have cost the British neurophysiologist his job Neurophysiologist Harold Hillman has a serious career problem. He’s out of step with his peers, and now he’s out of a job as well. For 15 years Hillman has been leading a scientist’s version of a double life. On the one hand, he has done mainstream neurological research and been a respected teacher of physiology. On the other, he has been questioning, needling,

Written byRichard Stevenson
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Neurophysiologist Harold Hillman has a serious career problem. He’s out of step with his peers, and now he’s out of a job as well.

For 15 years Hillman has been leading a scientist’s version of a double life. On the one hand, he has done mainstream neurological research and been a respected teacher of physiology. On the other, he has been questioning, needling, and increasingly infuriating those fellow biologists who use electron microscopy to study cells. Hillman says that the things scientists do to prepare specimens for the electron microscope so distort the objects’ structure that all observations and conclusions are suspect.

Perhaps because of Hillman’s personal charm, he has until recently been allowed to plow his lonely—and, most would say, arid—furrow. But now his relentless challenge to the scientific establishment may have finally caught up with him. His employer, the University of Surrey, has forced him to take early ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies